The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and by Moderna for children as young as 6 months on Friday, adding the final group to the nation’s vaccine program.
The regulator said Moderna’s MRNA two-dose vaccine is now authorized for children between the ages of 6 months and 17 years. It was previously authorized and is now fully approved for adults.
The…
